(Q35167171)

6 August 2017

title

How lipidomics provides new insight into drug discovery (English)

1 reference

6 August 2017

1 reference

Antonin Lamaziere

1

1 reference

6 August 2017

Claude Wolf

series ordinal

2

1 reference

6 August 2017

Peter J Quinn

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

12 May 2014

1 reference

Expert Opinion on Drug Discovery

6 August 2017

published in

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

819-836

1 reference

Application of lipidomics to assess lipogenesis in drug development and pre-clinical trials

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Lipidomics applications in health, disease and nutrition research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Lipidomics in longevity and healthy aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Lipidomics as a principal tool for advancing biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Nutritional lipidomics: molecular metabolism, analytics, and diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Statins in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Efficacy of short-term high-dose atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Emerging roles of lipids in BCL-2 family-regulated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Compensatory actions of orexinergic neurons in the lateral hypothalamus during metabolic or cortical challenges may enable the coupling of metabolic dysfunction and cortical dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Leptin and the central control of feeding behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Targeting intermediary metabolism in the hypothalamus as a mechanism to regulate appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Revealing the allosterome: systematic identification of metabolite-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Hypothalamic malonyl-CoA and the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Link between obesity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Mechanisms linking obesity and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Adipose tissue and adipocytes support tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Oxidation of phosphatidylserine: a mechanism for plasma membrane phospholipid scrambling during apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Anti-cancer role of SPARC, an inhibitor of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

SPARC in cancer biology: its role in cancer progression and potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

nab-Paclitaxel mechanisms of action and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

On respiratory impairment in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Activated lymphocytes as a metabolic model for carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Lactogenic hormones stimulate expression of lipogenic genes but not glucose transporters in bovine mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Acne and sebaceous gland function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Glucocorticoid metabolism in the developing lung: adrenal-like synthesis pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Antiobesity carbonic anhydrase inhibitors: a literature and patent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Acetyl-CoA carboxylase-a as a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Stearoyl-CoA desaturase inhibitors: update on patented compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Co-treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

The ketogenic diet for the treatment of pediatric status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Ketogenic diets: new advances for metabolism-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Structure and function of biotin-dependent carboxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Multi-subunit acetyl-CoA carboxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Herbicide resistance-endowing ACCase gene mutations in hexaploid wild oat (Avena fatua): insights into resistance evolution in a hexaploid species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Fatty acid transport across the cell membrane: regulation by fatty acid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Stable isotope approaches, applications, and issues related to polyunsaturated fatty acid metabolism studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Effects of sterculic acid on stearoyl-CoA desaturase in differentiating 3T3-L1 adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Manipulation of body fat composition with sterculic acid can inhibit mammary carcinomas in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

A role of DNA-PK for the metabolic gene regulation in response to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Effect of dietary fatty acids on inflammatory gene expression in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Fatty acid synthase inhibitors: new directions for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Direct interaction between USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Differential pharmacologic properties of the two C75 enantiomers: (+)-C75 is a strong anorectic drug; (-)-C75 has antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2014.914026

10.1517/17460441.2014.914026

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference